Rapid Influenza Diagnostic Tests-EMEA Market Status and Trend Report 2013-2023

Date: May 21, 2018
Pages: 157
Price:
US$ 3,480.00
Publisher: MIReports Co., Limited
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: R2FC980865F8EN
Leaflet:

Download PDF Leaflet

Rapid Influenza Diagnostic Tests-EMEA Market Status and Trend Report 2013-2023
Report Summary

Rapid Influenza Diagnostic Tests-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Rapid Influenza Diagnostic Tests industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole EMEA and Regional Market Size of Rapid Influenza Diagnostic Tests 2013-2017, and development forecast 2018-2023
Main market players of Rapid Influenza Diagnostic Tests in EMEA, with company and product introduction, position in the Rapid Influenza Diagnostic Tests market
Market status and development trend of Rapid Influenza Diagnostic Tests by types and applications
Cost and profit status of Rapid Influenza Diagnostic Tests, and marketing status
Market growth drivers and challenges

The report segments the EMEA Rapid Influenza Diagnostic Tests market as:

EMEA Rapid Influenza Diagnostic Tests Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa

EMEA Rapid Influenza Diagnostic Tests Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Influenza A
Influenza B

EMEA Rapid Influenza Diagnostic Tests Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Household
Other

EMEA Rapid Influenza Diagnostic Tests Market: Players Segment Analysis (Company and Product introduction, Rapid Influenza Diagnostic Tests Sales Volume, Revenue, Price and Gross Margin):
Alere
BD
Quidel
bioMrieux
CorisBioconcept
Meridian Bioscience
Response Biomedical (acquired by OrbiMed)
Princeton BioMeditech Corporation
SA Scientific
Sekisui Diagnostics
Thermo Fisher Scientific

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF RAPID INFLUENZA DIAGNOSTIC TESTS

1.1 Definition of Rapid Influenza Diagnostic Tests in This Report
1.2 Commercial Types of Rapid Influenza Diagnostic Tests
  1.2.1 Influenza A
  1.2.2 Influenza B
1.3 Downstream Application of Rapid Influenza Diagnostic Tests
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Household
  1.3.4 Other
1.4 Development History of Rapid Influenza Diagnostic Tests
1.5 Market Status and Trend of Rapid Influenza Diagnostic Tests 2013-2023
  1.5.1 EMEA Rapid Influenza Diagnostic Tests Market Status and Trend 2013-2023
  1.5.2 Regional Rapid Influenza Diagnostic Tests Market Status and Trend 2013-2023

CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Rapid Influenza Diagnostic Tests in EMEA 2013-2017
2.2 Consumption Market of Rapid Influenza Diagnostic Tests in EMEA by Regions
  2.2.1 Consumption Volume of Rapid Influenza Diagnostic Tests in EMEA by Regions
  2.2.2 Revenue of Rapid Influenza Diagnostic Tests in EMEA by Regions
2.3 Market Analysis of Rapid Influenza Diagnostic Tests in EMEA by Regions
  2.3.1 Market Analysis of Rapid Influenza Diagnostic Tests in Europe 2013-2017
  2.3.2 Market Analysis of Rapid Influenza Diagnostic Tests in Middle East 2013-2017
  2.3.3 Market Analysis of Rapid Influenza Diagnostic Tests in Africa 2013-2017
2.4 Market Development Forecast of Rapid Influenza Diagnostic Tests in EMEA 2018-2023
  2.4.1 Market Development Forecast of Rapid Influenza Diagnostic Tests in EMEA 2018-2023
  2.4.2 Market Development Forecast of Rapid Influenza Diagnostic Tests by Regions 2018-2023

CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole EMEA Market Status by Types
  3.1.1 Consumption Volume of Rapid Influenza Diagnostic Tests in EMEA by Types
  3.1.2 Revenue of Rapid Influenza Diagnostic Tests in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Europe
  3.2.2 Market Status by Types in Middle East
  3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Rapid Influenza Diagnostic Tests in EMEA by Types

CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Rapid Influenza Diagnostic Tests in EMEA by Downstream Industry
4.2 Demand Volume of Rapid Influenza Diagnostic Tests by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Rapid Influenza Diagnostic Tests by Downstream Industry in Europe
  4.2.2 Demand Volume of Rapid Influenza Diagnostic Tests by Downstream Industry in Middle East
  4.2.3 Demand Volume of Rapid Influenza Diagnostic Tests by Downstream Industry in Africa
4.3 Market Forecast of Rapid Influenza Diagnostic Tests in EMEA by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF RAPID INFLUENZA DIAGNOSTIC TESTS

5.1 EMEA Economy Situation and Trend Overview
5.2 Rapid Influenza Diagnostic Tests Downstream Industry Situation and Trend Overview

CHAPTER 6 RAPID INFLUENZA DIAGNOSTIC TESTS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA

6.1 Sales Volume of Rapid Influenza Diagnostic Tests in EMEA by Major Players
6.2 Revenue of Rapid Influenza Diagnostic Tests in EMEA by Major Players
6.3 Basic Information of Rapid Influenza Diagnostic Tests by Major Players
  6.3.1 Headquarters Location and Established Time of Rapid Influenza Diagnostic Tests Major Players
  6.3.2 Employees and Revenue Level of Rapid Influenza Diagnostic Tests Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 RAPID INFLUENZA DIAGNOSTIC TESTS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Alere
  7.1.1 Company profile
  7.1.2 Representative Rapid Influenza Diagnostic Tests Product
  7.1.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of Alere
7.2 BD
  7.2.1 Company profile
  7.2.2 Representative Rapid Influenza Diagnostic Tests Product
  7.2.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of BD
7.3 Quidel
  7.3.1 Company profile
  7.3.2 Representative Rapid Influenza Diagnostic Tests Product
  7.3.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of Quidel
7.4 bioMrieux
  7.4.1 Company profile
  7.4.2 Representative Rapid Influenza Diagnostic Tests Product
  7.4.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of bioMrieux
7.5 CorisBioconcept
  7.5.1 Company profile
  7.5.2 Representative Rapid Influenza Diagnostic Tests Product
  7.5.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of CorisBioconcept
7.6 Meridian Bioscience
  7.6.1 Company profile
  7.6.2 Representative Rapid Influenza Diagnostic Tests Product
  7.6.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of Meridian Bioscience
7.7 Response Biomedical (acquired by OrbiMed)
  7.7.1 Company profile
  7.7.2 Representative Rapid Influenza Diagnostic Tests Product
  7.7.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of Response Biomedical (acquired by OrbiMed)
7.8 Princeton BioMeditech Corporation
  7.8.1 Company profile
  7.8.2 Representative Rapid Influenza Diagnostic Tests Product
  7.8.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of Princeton BioMeditech Corporation
7.9 SA Scientific
  7.9.1 Company profile
  7.9.2 Representative Rapid Influenza Diagnostic Tests Product
  7.9.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of SA Scientific
7.10 Sekisui Diagnostics
  7.10.1 Company profile
  7.10.2 Representative Rapid Influenza Diagnostic Tests Product
  7.10.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of Sekisui Diagnostics
7.11 Thermo Fisher Scientific
  7.11.1 Company profile
  7.11.2 Representative Rapid Influenza Diagnostic Tests Product
  7.11.3 Rapid Influenza Diagnostic Tests Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF RAPID INFLUENZA DIAGNOSTIC TESTS

8.1 Industry Chain of Rapid Influenza Diagnostic Tests
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF RAPID INFLUENZA DIAGNOSTIC TESTS

9.1 Cost Structure Analysis of Rapid Influenza Diagnostic Tests
9.2 Raw Materials Cost Analysis of Rapid Influenza Diagnostic Tests
9.3 Labor Cost Analysis of Rapid Influenza Diagnostic Tests
9.4 Manufacturing Expenses Analysis of Rapid Influenza Diagnostic Tests

CHAPTER 10 MARKETING STATUS ANALYSIS OF RAPID INFLUENZA DIAGNOSTIC TESTS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference
Skip to top


Ask Your Question

Rapid Influenza Diagnostic Tests-EMEA Market Status and Trend Report 2013-2023
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: